Clinical trial
Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity…
NCT00478686 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00478686 |
|---|---|
| Title | Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine |
| Official title | A Retrospective Analysis of the Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Myrexis Inc. Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Intervention type | Procedure |
| Interventions | Phlebotomy |
| Enrollment | 102 |
| Start date | May 23, 2007 |
| Primary completion | May 2, 2017 |
| Completion | May 2, 2017 |
| First posted | May 25, 2007 |
| Last update posted | May 8, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: